Stem Cell Blog
Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.
The World Health Organisation (WHO) has declared Coronavirus (aka COVID-19) a “public health emergency of international concern”. With the number of cases continuing to increase and no vaccine or specific antiviral treatment currently available, finding a safe and effective therapeutic approach to treat patients infected with the virus has become priority.
02/01/2024 BlogNewsUses for Cord Tissue
This month saw publication of the results of a groundbreaking new trial into umbilical cord blood as a treatment for autism. The study showed enormous promise, with 75% of children showing an improvement in their condition.The medical centre responsible; Duke University, have now announced another ground breaking trial looking at umbilical cord tissue.
02/01/2024 BlogUses for Cord Tissue
There are many forms of macular disease affecting eyesight, the most common of which is age-related macular degeneration (AMD). In fact, AMD is the leading cause of sight loss in the developed world.
And, it is not just the old who are affected, juvenile macular dystrophies, covering a large number of inherited and rare conditions, often appear in childhood.
02/01/2024 NewsUses for Cord Tissue
The University of Warmia and Mazury, Poland have announced a trial into the use of cord tissue for treating amyotrophic lateral sclerosis (ALS), a debilitating and life-shortening form of motor neurone disease.
Currently, ALS is untreatable and the majority of sufferers die within two to five years of diagnosis, usually due to respiratory failure.
Duke University in North Carolina has been at the centre of some of the most exciting trials relating to the treatment of neurological conditions. Such has been the success of their safety and efficacy clinical trials, they are now able to offer cord blood therapy to any child who has access to a matched sample and is suffering from one of many conditions, including:
Cells4Life Group LLP,
Units 2-3 Oak House, Woodlands Office Park,
Albert Drive, Burgess Hill, RH15 9TN, UK.
Med Bio Genetics
Pero Nakov 110, Skopje, Republic Macedonia
+389 70 221 602
info@cells4life.mk
